The Technical Analyst
Senseonics Holdings Inc [SENS]
Exchange: AMEX Industry: Diagnostics & Research
Senseonics Holdings Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
-3.16% $0.466
America/New_York / 10 mai 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 247.29 mill |
| EPS: | -0.110 |
| P/E: | -4.24 |
| Earnings Date: | May 13, 2024 |
| SharesOutstanding: | 530.67 mill |
| Avg Daily Volume: | 2.57 mill |
| RATING 2024-05-10 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Buy | |
| P/E: | Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -4.24 | sector: PE 12.30 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.72x |
| Company: PE -4.24 | industry: PE 5.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.435 - 0.497 ( +/- 6.65%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-04-02 | Prince Douglas S | Buy | 15 931 | Common Stock |
| 2024-04-02 | Fiorentino Edward | Buy | 27 696 | Common Stock |
| 2024-04-02 | Steven Edelman | Buy | 25 245 | Common Stock |
| 2024-03-20 | Hansen Brian B | Sell | 2 619 048 | Stock Option (Right to Buy) |
| 2024-01-02 | Defalco Stephen P | Buy | 42 410 | Common Stock |
| INSIDER POWER |
|---|
| 4.69 |
| Last 98 transactions |
| Buy: 13 341 086 | Sell: 71 889 452 |
Forecast:
16:00 - $0.466
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $0.466
Forecast 2: 16:00 - $0.466
Forecast 3: 16:00 - $0.466
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.466 (-3.16% ) |
| Volume | 1.744 mill |
| Avg. Vol. | 2.57 mill |
| % of Avg. Vol | 68.00 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SENS
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
SENS
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Latest Press Releases
2024-05-09 16:05:00 - Press Release
Senseonics Partners With Rimidi To Develop Innovative Diabetes Solution
Germantown, md.--(business wire)--senseonics holdings, inc. (nyse american: sens), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (cgm) systems for people with diabetes, today announced a strategic partnership with rimidi, a leading clinical management platform designed to optimize clinical workflows, enhance patient experiences, and achieve quality objectives for chronic disease management, in the development of.
2024-05-02 08:05:00 - Press Release
Senseonics Holdings, Inc. To Participate In Upcoming Conferences
Germantown, md.--(business wire)--senseonics holdings, inc. (nyse american: sens), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (cgm) systems for people with diabetes, today announced plans to participate in the upcoming rbc capital markets global healthcare conference and the h.c. wainwright 2nd annual bioconnect investor conference, being held in new york, ny. management is scheduled to participate in the rbc.
2024-04-30 16:05:00 - Press Release
Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release And Conference Call For May 13, 2024 At 4:30 P.m. Eastern Time
Germantown, md.--(business wire)--senseonics holdings, inc. (nyse american: sens), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (cgm) systems for people with diabetes, today announced that it plans to release its first quarter 2024 financial results after market close on monday, may 13, 2024. management will hold a conference call to review the company's first quarter 2024 performance starting at 4:30 p.m. (eas.
2024-04-30 07:00:00 - Press Release
Eversense® Cgm System Receives Icgm Designation By The Us Fda
Germantown, md. & parsippany, n.j.--(business wire)--eversense® cgm system receives icgm designation by the us fda.
2024-03-12 07:00:00 - Press Release
Savings Offer For The Eversense E3 Cgm Extended To Cover Unlimited Number Of Systems
Eligible individuals in the u.s. will pay $99 out of pocket for each 6-month cgm system, offering each year of continuous glucose monitoring for just $200* parsippany, n.j. , march 12, 2024 /prnewswire/ -- ascensia diabetes care, a global diabetes care company and a subsidiary of phc holdings corporation (tse: 6523), and senseonics holdings, inc. (nyse american: sens), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (cgm) systems for people with diabetes, have announced a significant extension of the eversense payment assistance and simple savings (pass) program.
Latest News
2024-05-02 08:05:00 - Business Wire
Senseonics Holdings, Inc. to Participate in Upcoming Conferences
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming RBC Capital Markets Global Healthcare Conference and the H.C. Wainwright 2nd Annual BioConnect Investor Conference, being held in New York, NY. Management is scheduled to participate in the RBC.
2024-02-29 19:31:09 - Zacks Investment Research
Senseonics Holdings (SENS) Reports Q4 Loss, Tops Revenue Estimates
Senseonics Holdings (SENS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.01 per share a year ago.
2024-01-15 16:21:27 - InvestorPlace
3 Penny Stocks to Watch for Explosive Growth in Q1 2024
Some of the best penny stocks are primed to reach new heights in the first quarter of this year. I expect investor's risk tolerance to increase amid a broadening market breadth as the valuations of mega caps and large caps may be too rich to be sufficiently attractive.
2023-12-01 12:15:30 - PennyStocks
5 Hot Penny Stocks To Watch Today
Exploring the world of penny stocks offers exciting investment opportunities, but it requires astute strategies to identify real winners. In this update, we delve into essential techniques for finding penny stocks to buy and a list of cheap stocks to watch today.
2023-11-09 18:50:25 - Seeking Alpha
Senseonics Holdings, Inc. (SENS) Q3 2023 Earnings Call Transcript
Senseonics Holdings, Inc. (NYSE:SENS ) Q3 2023 Earnings Call Transcript November 9, 2023 4:30 PM ET Company Participants Trip Taylor - IR Tim Goodnow - President and CEO Rick Sullivan - CFO Mukul Jain - COO Conference Call Participants Marie Thibault - BTIG Jayson Bedford - Raymond James Operator Good day and welcome to the Senseonics Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.
2023-09-13 13:05:23 - PennyStocks
Best Penny Stocks To Buy Now? 10 Under $1 To Watch
Let's be honest – penny stocks priced at less than a buck hold an irresistible appeal. Even a small investment could potentially lead to insane returns.
2023-09-11 14:22:11 - PennyStocks
Best Penny Stocks To Buy Now? 7 Under $1 To Watch
Penny stocks priced under $1 per share have attracted a dedicated following among traders seeking massive returns. While penny stocks are inherently high-risk investments, the potential reward with these low-priced shares is exponentially higher compared to traditional blue chip stocks.
2023-09-06 13:21:07 - PennyStocks
3 Top Penny Stocks To Buy Now According To Insiders
The allure of penny stocks is undeniable. Their low price point, combined with the potential for high returns, makes them a tantalizing option for investors.
2023-08-10 20:31:08 - Zacks Investment Research
Senseonics Holdings (SENS) Reports Q2 Loss, Misses Revenue Estimates
Senseonics Holdings (SENS) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.03 per share a year ago.
2023-08-10 18:29:08 - Seeking Alpha
Senseonics Holdings, Inc. (SENS) Q2 2023 Earnings Call Transcript
Senseonics Holdings, Inc. (NYSE:SENS ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Philip Taylor - IR Tim Goodnow - President and CEO Rick Sullivan - CFO Conference Call Participants Colin Clark - Stifel Sam Eiber - BTIG Jayson Bedford - Raymond James Operator Good day, and welcome to the Senseonics Second Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.